Marco Platania

1.4k total citations
54 papers, 843 citations indexed

About

Marco Platania is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Marco Platania has authored 54 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 13 papers in Epidemiology. Recurrent topics in Marco Platania's work include Lung Cancer Research Studies (17 papers), Neuroendocrine Tumor Research Advances (13 papers) and Lung Cancer Treatments and Mutations (10 papers). Marco Platania is often cited by papers focused on Lung Cancer Research Studies (17 papers), Neuroendocrine Tumor Research Advances (13 papers) and Lung Cancer Treatments and Mutations (10 papers). Marco Platania collaborates with scholars based in Italy, Switzerland and Germany. Marco Platania's co-authors include Emilio Bajetta, Filippo de Braud, Laura Catena, Giuseppe Procopio, Elena Verzoni, Sara Pusceddu, Antonia Martinetti, Sara De Dosso, Barbara Formisano and E. Bichisao and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Marco Platania

51 papers receiving 825 citations

Peers

Countries citing papers authored by Marco Platania

Since Specialization

Citations

This map shows the geographic impact of Marco Platania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Platania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Platania more than expected).

Fields of papers citing papers by Marco Platania

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Platania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Platania. The network helps show where Marco Platania may publish in the future.

Co-authorship network of co-authors of Marco Platania

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Platania. A scholar is included among the top collaborators of Marco Platania based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Platania. Marco Platania is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current practices and challenges in the management of cancer-associated thrombosis: a survey of Italian oncologists 2025 ·Frontiers in Oncology ·Andrea Antonuzzo, Paola Ermacora, Gaetano Lanzetta, M Lucchesi, Marco Platania, Paolo Bossi	0
2	Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 2023 ·Future Oncology ·Stefano Cavalieri, Viviana Vitolo, Amelia Barcellini, Sara Ronchi, Angelica Facoetti, (unknown), Catherine Klersy, Silvia Molinelli, Francesco Agustoni, Virginia Valeria Ferretti, Annalisa De Silvestri, Marco Platania, Michele Del Vecchio, Marco Durante, Alexander Helm, Claudia Fournier, Filippo de Braud, Paolo Pedrazzoli, Ester Orlandi, Lisa Licitra	13
3	Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma 2021 ·Tumori Journal ·Leonardo Provenzano, Valeria Cuccarini, Marco Platania, (unknown), A. Spagnoletti, Fabio Martino Doniselli, Marica Eoli, Arsela Prelaj, Elena Anghileri	1
4	1182P Baseline neutrophil-lymphocyte ratio and its variations after adjuvant radiotherapy predict clinical survival outcomes in locally advanced Merkel cell carcinoma (MCC) 2020 ·Annals of Oncology ·Martina Torchio, Francesca Corti, Paolo Manca, Natalie Prinzi, Marco Platania, Andrea Maurichi, (unknown), Roberto Patuzzo, (unknown), Massimo Milione, Laura Cattaneo, (unknown), Michele Prisciandaro, Alessandra Raimondi, Filippo Pagani, Elena Colombo, Jorgelina Coppa, Maria Di Bartolomeo, Filippo de Braud, Sara Pusceddu	1
5	Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis 2019 ·Oncology Research and Treatment ·Giulia Galli, Stefano Cavalieri, Lorenza Di Guardo, Carolina Cimminiello, Federico Nichetti, Francesca Corti, (unknown), (unknown), C. Fallai, Filippo de Braud, Marco Platania, Michele Del Vecchio	19
6	Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer 2019 ·Lung Cancer ·M. Pérol, Nick Pavlakis, E. Levchenko, Marco Platania, Júlio Oliveira, Silvia Novello, Rita Chiari, Teresa Morán, Emmanuel Mitry, Eveline Nüesch, Ting Liu, Bogdana Balas, Krzysztof Konopa, Solange Peters	27
7	138PD_PR Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC) 2018 ·Journal of Thoracic Oncology ·M. Pérol, Solange Peters, Nick Pavlakis, E. Levchenko, Marco Platania, Júlio Oliveira, Silvia Novello, Tom C. Karagiannis, Ali Zeaiter, Rafał Dziadziuszko	1
8	Pro-GRP in small cell lung cancer 2017 ·Annals of Oncology ·Stefano Cavalieri, Federico Nichetti, Daniele Morelli, Filippo de Braud, Antonia Martinetti, Elisa Sottotetti, Katia Dotti, Michele Prisciandaro, Francesca Corti, Marco Platania	1
9	Pro-gastrin releasing peptide (pro-GRP) in small cell lung cancer staging 2016 ·Annals of Oncology ·Stefano Cavalieri, Alessandra Raimondi, Daniele Morelli, Antonia Martinetti, Filippo de Braud, Francesco Agustoni, Katia Dotti, Giulia Galli, Claudio Vernieri, Giovanni Fucà, (unknown), Michele Prisciandaro, Federico Nichetti, (unknown), Giuseppe Lo Russo, Natalie Prinzi, Marina Chiara Garassino, Marco Platania	1
10	Treatment of lung large cell neuroendocrine carcinoma 2016 ·Tumor Biology ·Giuseppe Lo Russo, Sara Pusceddu, Claudia Proto, Marianna Macerelli, Diego Signorelli, Milena Vitali, Monica Ganzinelli, Rosaria Gallucci, Nicoletta Zilembo, Marco Platania, Roberto Buzzoni, Filippo de Braud, Marina Chiara Garassino	45
11	Lume trial: searching for survival prognostic factors in malignant pleural mesothelioma 2015 ·Annals of Oncology ·Claudia Proto, Giuseppe Lo Russo, Marianna Macerelli, Milena Vitali, Francesco Agustoni, Marco Platania, Nicoletta Zilembo, Monica Ganzinelli, Marcello Tiseo, Giulia Pasello, Rosaria Gallucci, Maria Silvia Cona, Laura Botta, Annalisa Trama, Filippo de Braud, Marina Chiara Garassino, Diego Signorelli	1
12	Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study 2014 ·Annals of Oncology ·Roberto Buzzoni, Sara Pusceddu, Emilio Bajetta, Filippo de Braud, Marco Platania, Claudio Iannacone, Maurizio Cantore, Andrea Mambrini, A. Bertolini, Oscar Alabiso, A. Ciarlo, (unknown), Vincenzo Mazzaferro	60
13	Gingival Metastasis as First Sign of Multiorgan Dissemination of Epithelioid Malignant Mesothelioma 2014 ·Journal of Thoracic Oncology ·Andrea Billè, Marco Platania, Giuseppe Pelosi, (unknown), Pasquale Quattrone, Ugo Pastorino	5
14	Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations 2014 ·Critical Reviews in Oncology/Hematology ·Eva Regina Haspinger, Francesco Agustoni, Valter Torri, Francesco Gelsomino, Marco Platania, Nicoletta Zilembo, Rosaria Gallucci, Marina Chiara Garassino, Michela Cinquini	41
15	Single-Institution Series of Early-Stage Merkel Cell Carcinoma: Long-Term Outcomes in 95 Patients Managed with Surgery Alone 2009 ·Annals of Surgical Oncology ·Emilio Bajetta, Luigi Celio, Marco Platania, Salvatore Lo Vullo, Roberto Patuzzo, Andrea Maurichi, Mario Santinami	47
16	Primary Uterine Cervix Melanoma Resembling Malignant Peripheral Nerve Sheath Tumor: A Case Report 2008 ·International Journal of Gynecological Pathology ·Sara Pusceddu, Emilio Bajetta, Roberto Buzzoni, Maria Luisa Carcangiu, Marco Platania, Michele Del Vecchio, Antonino Ditto	13
17	MERKEL CELL CARCINOMAAFTER LIVER TRANSPLANTATION: A CASE REPORT 2007 ·Tumori ·Emilio Bajetta, Marco Platania, Laura Catena, E. Bichisao, Alessandra Fabbri, Giuseppe Procopio, Sara De Dosso, Roberto Buzzoni	1
18	Safety and Activity of Sorafenib in Different Histotypes of Advanced Renal Cell Carcinoma 2007 ·Oncology ·Giuseppe Procopio, Elena Verzoni, Arpine Gevorgyan, (unknown), Sara Pusceddu, Laura Catena, Marco Platania, Valentina Guadalupi, Antonia Martinetti, Emilio Bajetta	20
19	Pulmonary Carcinoid Tumours: Indolent but Not Benign 2007 ·Oncology ·Sara De Dosso, Emilio Bajetta, Giuseppe Procopio, Diego Cortinovis, Roberto Buzzoni, Laura Catena, Marco Platania, Elena Verzoni	18
20	Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? 2006 ·Cancer Chemotherapy and Pharmacology ·Emilio Bajetta, Laura Catena, Giuseppe Procopio, Sara De Dosso, E. Bichisao, Leonardo Ferrari, Antonia Martinetti, Marco Platania, Elena Verzoni, Barbara Formisano, (unknown)	171

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact